Poseida Therapeutics Inc
(PSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 0 | 0 | 17,589 | 9,464 | 14,797 |
| Cost of Goods | N/A | N/A | 10,038 | 5,116 | 7,334 |
| Gross Profit | N/A | N/A | 7,551 | 4,348 | 7,463 |
| Operating Expenses | 41,989 | 0 | 9,607 | 7,126 | 9,982 |
| Operating Income | -41,989 | N/A | -2,018 | -2,662 | -2,185 |
| Interest Expense | 1,796 | 0 | 106 | 0 | 7 |
| Other Income | -821 | 0 | -2 | 789 | 3,335 |
| Pre-tax Income | -44,606 | 0 | -2,126 | -1,874 | 1,143 |
| Income Tax | -202 | N/A | 75 | 26 | -857 |
| Net Income Continuous | -44,404 | N/A | -2,202 | -1,900 | 2,000 |
| Net Income | $-44,404 | $N/A | $-2,202 | $-1,900 | $2,000 |
| EPS Basic Total Ops | -3.64 | N/A | -0.08 | -0.08 | 0.08 |
| EPS Basic Continuous Ops | -3.64 | N/A | -0.06 | -0.06 | 0.09 |
| EPS Diluted Total Ops | -3.64 | N/A | -0.08 | -0.08 | 0.06 |
| EPS Diluted Continuous Ops | -3.64 | N/A | -0.06 | -0.06 | 0.07 |
| EBITDA(a) | $-40,769 | $N/A | $101 | $-1,755 | $-1,293 |